© 1995 Oxford University Press
OTHER |
The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac
and ß myosin heavy chain genes on chromosome 14q11.2q13
Centre for Research in Neurosciences, McGill University, and the Montréal General Hospital 1650 Cedar Avenue, Montréal, Québec H3G 1A4 1Departments of Epidemiology and Biostatistics, Human Genetics, McGill University 1020 Pine Avenue, Montréal, Québec H3A 1A2, Canada 2 Généthon Evry 91000, France 3Department of Neurology, Sackler School of Medicine Ramat Aviv 69978, Israel 4 INSERM U.153, 17, rue du Fer-à-Moulin, 75005 Paris, France 5Départment des sciences neurologiques, Hôpital de I'Enfant-Jésus 1401, 18e rue, Québec, Québec G1J 1Z4, Canada
*To whom correspondence should be addressed
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset autosomal dominant muscular dystrophy which presents typically after the age of 50 with progressive eyelid drooping and an increasing difficulty in swallowing. Though OPMD has a world-wide incidence, it is more common in the French Canadian population. We have identified a homogeneous group of families and studied 166 polymorphic markers as part of a genome search before establishing linkage to chromosome 14. We determined that the OPMD locus maps to a less than 5 cM region of chromosome 14q11.2q13. The maximum twopoint lod score in three French Canadian families of 14.73 (
= 0.03) was obtained for an intronic cardiac ß myosin heavy chain gene (MYH7) marker. The regional localization for the OPMD locus raises the intriguing possibility that either the cardiac
or ß myosin heavy chain genes may play a role in this disease
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Abu-Baker, C. Messaed, J. Laganiere, C. Gaspar, B. Brais, and G. A. Rouleau Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy Hum. Mol. Genet., October 16, 2003; 12(20): 2609 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fan, P. Dion, J. Laganiere, B. Brais, and G. A. Rouleau Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death Hum. Mol. Genet., October 1, 2001; 10(21): 2341 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Blumen, A. D. Korczyn, H. Lavoie, S. Medynski, J. Chapman, A. Asherov, P. Nisipeanu, R. Inzelberg, R. L. Carasso, J.-P. Bouchard, et al. Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene Neurology, November 14, 2000; 55(9): 1267 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mirabella, G. Silvestri, G. de Rosa, S. Di Giovanni, A. Di Muzio, A. Uncini, P. Tonali, and S. Servidei GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy Neurology, February 8, 2000; 54(3): 608 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Grewal, J. D. Karkera, R. K. Grewal, and S. D. Detera-Wadleigh Mutation Analysis of Oculopharyngeal Muscular Dystrophy in Hispanic American Families Arch Neurol, November 1, 1999; 56(11): 1378 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Servidei, F. Capon, A. Spinazzola, M. Mirabella, S. Semprini, G. de Rosa, M. Gennarelli, F. Sangiuolo, E. Ricci, H. W. Mohrenweiser, et al. A distinctive autosomal dominant vacuolar neuromyopathy linked to 19p13 Neurology, September 1, 1999; 53(4): 830 - 830. [Abstract] [Full Text] [PDF] |
||||


